Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Clinical trial NCT01126138 · UNKNOWN

Trial details

NCT number: NCT01126138
Sponsor: Chinese Academy of Medical Sciences
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Invasive Ductal, Breast

Start date: 2010-07-01
Primary completion: 2015-05-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.